SCHEMBL30948988

SCHEMBL30948988

Cc1nc(N[C@@H]2CN(C(=O)OC(C)(C)C)C[C@@H]2C)ccc1-c1ncccn1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 2/20 0.43
▸ MC4R P32245 1/20 0.42
▸ SSTR4 P31391 1/20 0.40
▸ BACE1 P56817 3/20 0.40
▸ POLB P06746 1/20 0.39
▸ ADAM17 P78536 3/20 0.39
▸ GPR119 Q8TDV5 2/20 0.38
▸ ACHE P22303 1/20 0.38
▸ MMP12 P39900 2/20 0.38
▸ MMP3 P08254 1/20 0.38
▸ MMP7 P09237 1/20 0.38
▸ MMP10 P09238 1/20 0.38
▸ MMP8 P22894 1/20 0.38
▸ HCRTR1 O43613 2/20 0.38
▸ HCRTR2 O43614 2/20 0.38
▸ BACE2 Q9Y5Z0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30458036 0.83 MC4R (0.57) USP30MC4RGPR119
SCHEMBL30833316 0.83 MC4R (0.57) USP30MC4RGPR119
SCHEMBL31634709 0.81 MC4R (0.40) MC4RSSTR4POLBGPR119ACHE
SCHEMBL31634692 0.78 POLB (0.43) MC4RPOLBHCRTR1HCRTR2
SCHEMBL31634729 0.74 MC4R (0.48) USP30MC4R
SCHEMBL30948979 0.74 MC4R (0.48) USP30MC4R
SCHEMBL31634691 0.74 MC4R (0.76) MC4RHCRTR1HCRTR2
SCHEMBL31634693 0.74 MC4R (0.76) MC4RHCRTR1HCRTR2
SCHEMBL31634727 0.73 MC4R (0.49) USP30MC4R
SCHEMBL31634722 0.72 MC4R (0.46) USP30MC4RGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120202199-A MC4R antagonist compound, pharmaceutical composition and application thereof in medicine 长春金赛药业有限责任公司 2025-06-24 — — CN disclosed
WO-2024104452-A1 MC4R ANTAGONIST COMPOUND, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL USE THEREOF 长春金赛药业有限责任公司 2024-05-23 — — WO disclosed
Send feedback